The global healthcare industry is witnessing consistent demand for antidiarrheal medications due to the rising prevalence of gastrointestinal disorders, increasing awareness regarding digestive health, and expanding access to over-the-counter treatments. Antidiarrheal drugs are widely used to manage symptoms associated with acute and chronic diarrhea caused by infections, inflammatory bowel...

"Comprehensive Outlook on Executive Summary Gastrointestinal Diseases Drug Development Market Size and Share CAGR Value The global gastrointestinal diseases drug development market size was valued at USD 39.60 billion in 2024 and is expected to reach USD 51.35 billion by 2032, at a CAGR of 3.30% during the forecast period Taking up Gastrointestinal...